AEMD Financials

Income Statement
MetricQ2 2027Q1 2027Q4 2026Q3 2026Q2 2026
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
2.7M
+69.4%
1.6M
-18.1%
1.9M
-6.4%
2.1M
+36.6%
1.5M
R&D
0
0
0
0
0
SG&A
2.7M
+69.4%
1.6M
-18.1%
1.9M
-6.4%
2.1M
+36.6%
1.5M
Operating Income
-2675028
-69.4%
-1579202
+18.1%
-1929296
+6.4%
-2062116
-36.6%
-1509830
EBITDA
-2594878
-72.3%
-1506342
+18.6%
-1849749
+6.6%
-1980513
-38.5%
-1429964
Net Income
-2617507
-69.1%
-1547912
+17.9%
-1884266
+6.6%
-2018245
-35.7%
-1487100
EPS (Basic)
$-2.60
+35.3%
$-4.02
+45.9%
$-7.43
+39.3%
$-12.25
+34.5%
$-18.70
EPS (Diluted)
$-2.60
+35.3%
$-4.02
+45.9%
$-7.43
+39.3%
$-12.25
+34.5%
$-18.70
Shares (Diluted)
1.0M
+161.9%
384.7K
+51.8%
253.5K
+54.0%
164.6K
+107.1%
79.5K
AETHLON MEDICAL (AEMD) — Financials